Measuring dyspnoea: New multidimensional instruments to match our 21st century understanding

European Respiratory Journal

Volumn 49, Issue 3, 2017, Pages

  Banzett, Robert B ^a,b   Moosavi, Shakeeb H ^c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; DYSPNEA; DYSPNEA 12; HUMAN; MULTIDIMENSIONAL DYSPNEA PROFILE; RESPIRATORY TRACT DISEASE ASSESSMENT; REVIEW; HISTORY;

DYSPNEA; HISTORY, 21ST CENTURY; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 85014487373     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.02473-2016     Document Type: Review

References (54)

1. Williams M, John D, Frith P. Comparison of the Dyspnoea-12 and Multidimensional Dyspnoea Profile in people with COPD. Eur Respir J 2017; 49: 1600773.
2. Comroe JH. Dyspnea. Mod Concepts Cardiovasc Dis 1956; 25: 347-349.
3. Oswald NC, Waller RE, Drinkwater J. Relationship between breathlessness and anxiety in asthma and bronchitis: a comparative study. Br Med J 1970; 2: 14-17.
4. Elliott MW, Adams L, Cockcroft A, et al. The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. Am Rev Respir Dis 1991; 144: 826-832.
5. Simon PM, Schwartzstein RM, Weiss JW, et al. Distinguishable sensations of breathlessness induced in normal volunteers. Am Rev Respir Dis 1989; 140: 1021-1027.
6. Simon PM, Schwartzstein RM, Weiss JW, et al. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 1990; 142: 1009-1014.
7. Carrieri-Kohlman V, Gormley JM, Douglas MK, et al. Exercise training decreases dyspnea and the distress and anxiety associated with it. Monitoring alone may be as effective as coaching. Chest 1996; 110: 1526-1535.
8. Gift AG. Psychologic and physiologic aspects of acute dyspnea in asthmatics. Nurs Res 1991; 40: 196-199.
9. ATS ad hoc Committee. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med 1999; 159: 321-340.
10. Parshall MB, Schwartzstein RM, Adams L, et al. An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea. Am J Respir Crit Care Med 2012; 185: 435-452.
11. Laviolette L, Laveneziana P. Dyspnoea: a multidimensional and multidisciplinary approach. Eur Respir J 2014; 43: 1750-1762.
12. Dallenbach K. Somesthesis. In: Boring EG, Langfield HS, Weld HP, eds. Introduction to Psychology. New York, Wiley and Sons, 1939; pp. 608-625.
13. Wade JB, Dougherty LM, Archer CR, et al. Assessing the stages of pain processing: a multivariate analytical approach. Pain 1996; 68: 157-167.
14. Price DD. Psychological and neural mechanisms of the affective dimension of pain. Science 2000; 288: 1769-1772.
15. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1: 277-299.
16. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005; 113: 9-19.
17. Piotrowski C. Assessment of pain: a survey of practicing clinicians. Percept Mot Skills 1998; 86: 181-182.
18. Majani G, Tiengo M, Giardini A, et al. Relationship between MPQ and VAS in 962 patients. A rationale for their use. Minerva Anestesiol 2003; 69: 67-73.
19. Gilron I, Tu D, Holden RR. Sensory and affective pain descriptors respond differentially to pharmacological interventions in neuropathic conditions. Clin J Pain 2013; 29: 124-131.
20. Gracely RH, McGrath P, Dubner R. Validity and sensitivity of ratio scales of sensory and affective verbal pain descriptors: manipulation of affect by diazepam. Pain 1978; 5: 19-29.
21. Gracely RH, Dubner R, McGrath PA. Narcotic analgesia: fentanyl reduces the intensity but not the unpleasantness of painful tooth pulp sensations. Science 1979; 203: 1261-1263.
22. Melzack R. The McGill Pain Questionnaire: from description to measurement. Anesthesiology 2005; 103: 199-202.
23. Yorke J, Moosavi SH, Shuldham C, et al. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 2010; 65: 21-26.
24. Yorke J, Savin C. Evaluating tools that can be used to measure and manage breathlessness in chronic disease. Nurs Times 2010; 106: 10, 12-13.
25. Parshall MB. Psychometric characteristics of dyspnea descriptor ratings in emergency department patients with exacerbated chronic obstructive pulmonary disease. Res Nurs Health 2002; 25: 331-344.
26. Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol 2009; 167: 53-60.
27. Banzett RB, O'Donnell CR, Guilfoyle TE, et al. Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research. Eur Respir J 2015; 45: 1681-1691.
28. Banzett R, Moosavi S. Dyspnea and pain: similarities and contrasts between two very unpleasant sensations. Am Pain Soc Bull 2001; 11: 1&6-8.
29. Morelot-Panzini C, Gilet H, Aguilaniu B, et al. Real-life assessment of the multidimensional nature of dyspnoea in COPD outpatients. Eur Respir J 2016; 47: 1668-1679.
30. Santos M, Kitzman DW, Matsushita K, et al. Prognostic importance of dyspnea for cardiovascular outcomes and mortality in persons without prevalent cardiopulmonary disease: The Atherosclerosis Risk in Communities Study. PLoS One 2016; 11: e0165111.
31. Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440.
32. Banzett RB, Adams L, O'Donnell CR, et al. Using laboratory models to test treatment: morphine reduces dyspnea and hypercapnic ventilatory response. Am J Respir Crit Care Med 2011; 184: 920-927.
33. Banzett RB, Pedersen SH, Schwartzstein RM, et al. The affective dimension of laboratory dyspnea: air hunger is more unpleasant than work/effort. Am J Respir Crit Care Med 2008; 177: 1384-1390.
34. Meek PM, Banzett R, Parshall MB, et al. Reliability and validity of the multidimensional dyspnea profile. Chest 2012; 141: 1546-1553.
35. Parshall MB, Meek PM, Sklar D, et al. Test-retest reliability of multidimensional dyspnea profile recall ratings in the emergency department: a prospective, longitudinal study. BMC Emerg Med 2012; 12: 6.
36. O'Donnell CR, Schwartzstein RM, Lansing RW, et al. Dyspnea affective response: comparing COPD patients with healthy volunteers and laboratory model with activities of daily living. BMC Pulm Med 2013; 13: 27.
37. Beaumont M, Mialon P, Le Ber-Moy C, et al. Inspiratory muscle training during pulmonary rehabilitation in chronic obstructive pulmonary disease: a randomized trial. Chron Respir Dis 2015; 12: 305-312.
38. Hauzer R, Verheul W, Griez E, et al. Medically unexplained dyspnoea and panic. Respirology 2015; 20: 828-830.
39. Loprinzi PD, Kane C, Sigler S, et al. Free-living physical activity characteristics, activity-related air trapping and breathlessness, and utilization of transtheoretical constructs in COPD: A pilot study. Physiol Behav 2015; 152: 79-84.
40. Georges M, Moraviec E, Raux M, et al. Cortical drive to breathe in amyotrophic lateral sclerosis: a dyspnoea-worsening defence? Eur Respir J 2016; 47: 1818-1828.
41. O'Donnell CR, Lansing RW, Schwartzstein RM, et al. The effect of aerosol saline on laboratory-induced dyspnea. Lung 2017; 195: 37-42.
42. Yorke J, Russell AM, Swigris J, et al. Assessment of dyspnea in asthma: validation of the Dyspnea-12. J Asthma 2011; 48: 602-608.
43. Yorke J, Swigris J, Russell AM, et al. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest 2011; 139: 159-164.
44. Yorke J, Armstrong I. The assessment of breathlessness in pulmonary arterial hypertension: reliability and validity of the Dyspnoea-12. Eur J Cardiovasc Nurs 2014; 13: 506-514.
45. Tan JY, Yorke J, Harle A, et al. Assessment of breathlessness in lung cancer: psychometric properties of the Dyspnea-12 questionnaire. J Pain Symptom Manage 2016.
46. Lee BY, Lee S, Lee JS, et al. Validity and reliability of CAT and Dyspnea-12 in bronchiectasis and tuberculous destroyed lung. Tuberc Respir Dis (Seoul) 2012; 72: 467-474.
47. Bausewein C, Booth S, Higginson IJ. Measurement of dyspnoea in the clinical rather than the research setting. Curr Opin Support Palliat Care 2008; 2: 95-99.
48. Dorman S, Byrne A, Edwards A. Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliat Med 2007; 21: 177-191.
49. Stenton C. The MRC breathlessness scale. Occup Med (Lond) 2008; 58: 226-227.
50. Mahler DA, Weinberg DH, Wells CK, et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751-758.
51. Stevens JP, Baker K, Howell MD, et al. Prevalence and predictive value of dyspnea ratings in hospitalized patients: pilot studies. PLoS One 2016; 11: e0152601.
52. Schmidt M, Banzett RB, Raux M, et al. Unrecognized suffering in the ICU: addressing dyspnea in mechanically ventilated patients. Intensive Care Med 2014; 40: 1-10.
53. Lanken PN, Terry PB, Delisser HM, et al. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med 2008; 177: 912-927.
54. Al-Gamal E, Yorke J, Al-Shwaiyat MK. Dyspnea-12-Arabic: testing of an instrument to measure breathlessness in Arabic patients with chronic obstructive pulmonary disease. Heart Lung 2014; 43: 244-248.